-The Hindu Business Line It’s only an open-ended deal with co-developer Bharat Biotech, says top source The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, COVAXin, with any company as the contract with co-developer Bharat Biotech is not close-ended. Currently, Bharat Biotech has the sole licence to manufacture COVAXin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology...

-The Hindu 12 Republican lawmakers write a seven-page letter to U.S. Trade Representative Katherine Tai on the issue U.S. President Joe Biden said on Tuesday that he had not made a decision on whether the U.S. would support an Indian and South African initiative at the World Trade Organisation (WTO) to waive Trade Related Intellectual Property Rights (TRIPS) to facilitate the production of COVID-19 related vaccines and therapeutics around the world. “Well, we’re...

-The Hindu She stresses on the protection that vaccines can offer against disease The current COVID-19 surge in India may begin to start tapering between the middle and end of May, virologist Gagandeep Kang said on Wednesday. At a virtual interaction with members of the Indian Women Press Corps, Dr. Kang said, “Best guess estimates from a number of models put this somewhere between the middle and end of the month. Some models...

-The Telegraph Centre’s revised policy has more than doubled the population of potential beneficiaries without immediate provisions for the extra doses needed India is likely to face extreme shortages of Covid-19 vaccines if all adults eligible for vaccination begin queuing up for the jabs from May 1, health and industry experts have said. The Centre’s revised vaccination policy has more than doubled the population of potential vaccine beneficiaries without immediate provisions for the...

-The Telegraph The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or COVAXin India’s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government’s lack of funding for key vaccines under development and evaluation, experts have said. The experts, who have tracked global vaccine efforts, said the Indian government’s lack of investments contrasted with the...